Acadia Healthcare (NASDAQ:ACHC) Shares Gap Down – Should You Sell?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s stock price gapped down prior to trading on Thursday . The stock had previously closed at $14.33, but opened at $13.85. Acadia Healthcare shares last traded at $15.0450, with a volume of 1,552,705 shares.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on ACHC shares. Cantor Fitzgerald set a $17.00 price objective on Acadia Healthcare in a research note on Wednesday, December 3rd. UBS Group cut their price target on shares of Acadia Healthcare from $28.00 to $24.00 and set a “buy” rating for the company in a report on Wednesday, December 3rd. Raymond James Financial set a $17.00 price target on shares of Acadia Healthcare in a research report on Wednesday, December 3rd. Leerink Partners lowered shares of Acadia Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, December 3rd. Finally, Jefferies Financial Group downgraded Acadia Healthcare to a “hold” rating in a report on Thursday. Six analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, Acadia Healthcare has a consensus rating of “Hold” and an average target price of $18.62.

Acadia Healthcare Price Performance

The stock has a 50-day simple moving average of $14.50 and a 200 day simple moving average of $19.74. The stock has a market capitalization of $1.42 billion, a P/E ratio of 13.19, a price-to-earnings-growth ratio of 3.73 and a beta of 0.88. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.44 and a current ratio of 1.44.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share for the quarter, topping analysts’ consensus estimates of $0.71 by $0.01. The company had revenue of $851.57 million during the quarter, compared to the consensus estimate of $852.43 million. Acadia Healthcare had a return on equity of 7.66% and a net margin of 3.29%.The firm’s quarterly revenue was up 4.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. On average, equities analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

Hedge funds and other institutional investors have recently bought and sold shares of the business. Envestnet Portfolio Solutions Inc. increased its holdings in Acadia Healthcare by 256.4% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 26,053 shares of the company’s stock valued at $591,000 after purchasing an additional 18,742 shares during the last quarter. Oppenheimer Asset Management Inc. increased its stake in shares of Acadia Healthcare by 85.1% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 28,683 shares of the company’s stock valued at $651,000 after acquiring an additional 13,188 shares during the last quarter. Janney Montgomery Scott LLC acquired a new stake in shares of Acadia Healthcare in the 2nd quarter valued at approximately $479,000. Caxton Associates LLP increased its stake in Acadia Healthcare by 1,234.5% in the second quarter. Caxton Associates LLP now owns 173,482 shares of the company’s stock valued at $3,936,000 after purchasing an additional 160,482 shares in the last quarter. Finally, Truist Financial Corp raised its holdings in Acadia Healthcare by 85.6% in the second quarter. Truist Financial Corp now owns 82,741 shares of the company’s stock worth $1,877,000 after purchasing an additional 38,167 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.